Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment

NCT03536780 is registered in ClinicalTrials.gov with Gachon University Gil Medical Center as lead sponsor.

NCT NCT03536780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03536780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
Lead sponsor
Gachon University Gil Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2018
Completion date
December 31, 2022
Enrollment
38 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyosarcoma metastatic